Table 1 Descriptive statistics of central baseline variables and covariates (N = 320).

From: Recent cannabis use affects the association between baseline immune markers and long-term outcomes in psychosis

 

N

%

Sex (f/m)

134/186

41.9/58.1

Diagnosis

  

 Bipolar Disorder

78

24.4

 Other Psychosis

88

27.5

 Schizophrenia Spectrum

154

48.1

Daily nicotine (n/y)a

146/171

45.6/53.4

Cannabis use (n/y)b

242/71

75.6/22.2

 

Median

IQR

Age

25.00

11.25

PDD/DDDc

0.67

0.94

CRPd

1.81

2.84

IL-1RAe,f

204.50

307.12

sIL-2Re,g

0.26

0.18

sgp130e,g

205.37

56.09

sTNFR1e,g

1.68

0.61

  1. Concentrations of immune markers (CRP, IL-1RA, sIL-2R, sgp130, sTNFR1) are shown on their original, non-transformed scale.
  2. IQR interquartile range, PDD/DDD antipsychotic medication load.
  3. aMissing: n = 3.
  4. bMissing: n = 7.
  5. cMissing: n = 1.
  6. dmg/L
  7. eMissing: n = 4.
  8. fpg/ml.
  9. gng/ml.
Back to article page